Unexpected Hair Loss Reported After Single-Dose Intravesical Gemcitabine in Bladder Cancer Patients: Case Series
USA: Researchers have drawn attention to an unusual but potentially distressing adverse effect linked to a commonly used postoperative treatment for non–muscle-invasive bladder cancer (NMIBC). A multi-institutional case series published…